| Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions Y Chung, S Tanaka, F Chu, RI Nurieva, GJ Martinez, S Rawal, YH Wang, ... Nature medicine 17 (8), 983-988, 2011 | 1175 | 2011 |
| Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial JR Westin, F Chu, M Zhang, LE Fayad, LW Kwak, N Fowler, J Romaguera, ... The lancet oncology 15 (1), 69-77, 2014 | 638 | 2014 |
| Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development X Liu, X Chen, B Zhong, A Wang, X Wang, F Chu, RI Nurieva, X Yan, ... Nature 507 (7493), 513-518, 2014 | 359 | 2014 |
| The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally … J Liu, Y Sun, J Qi, F Chu, H Wu, F Gao, T Li, J Yan, GF Gao The Journal of infectious diseases 202 (8), 1171-1180, 2010 | 163 | 2010 |
| Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase D Xu, Z Zhang, L Jin, F Chu, Y Mao, H Wang, M Liu, M Wang, L Zhang, ... European Journal of Clinical Microbiology & Infectious Diseases 24 (3), 165-171, 2005 | 137 | 2005 |
| Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China T Ya, Q Zhang, F Chu, J Merritt, M Bilige, T Sun, R Du, H Zhang BMC immunology 9, 1-9, 2008 | 135 | 2008 |
| Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment S Rawal, F Chu, M Zhang, HJ Park, D Nattamai, S Kannan, R Sharma, ... The Journal of Immunology 190 (12), 6681-6693, 2013 | 112 | 2013 |
| CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ... Blood, The Journal of the American Society of Hematology 138 (12), 1081-1085, 2021 | 104 | 2021 |
| Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease F Mao, Q Tu, L Wang, F Chu, X Li, HS Li, W Xu Oncotarget 8 (23), 38008, 2017 | 95 | 2017 |
| Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study. LJ Nastoupil, JR Westin, NH Fowler, MA Fanale, F Samaniego, Y Oki, ... Journal of Clinical Oncology 35 (15_suppl), 7519-7519, 2017 | 52 | 2017 |
| CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity F Chu, HS Li, X Liu, J Cao, W Ma, Y Ma, J Weng, Z Zhu, X Cheng, Z Wang, ... Leukemia 33 (11), 2640-2653, 2019 | 49 | 2019 |
| First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A* 01 complexed with two immunogenic SIV epitopes and insights into CTL escape F Chu, Z Lou, YW Chen, Y Liu, B Gao, L Zong, AH Khan, JI Bell, Z Rao, ... The Journal of Immunology 178 (2), 944-952, 2007 | 40 | 2007 |
| Selective targeting of Toll‐like receptors and OX40 inhibit regulatory T–cell function in follicular lymphoma KS Voo, M Foglietta, E Percivalle, F Chu, D Nattamai, M Harline, ST Lee, ... International journal of cancer 135 (12), 2834-2846, 2014 | 39 | 2014 |
| TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas J Weng, S Rawal, F Chu, HJ Park, R Sharma, DA Delgado, L Fayad, ... Blood, The Journal of the American Society of Hematology 120 (8), 1613-1623, 2012 | 38 | 2012 |
| Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma LJ Nastoupil, CK Chin, JR Westin, NH Fowler, F Samaniego, X Cheng, ... Blood Advances 6 (4), 1143-1151, 2022 | 29 | 2022 |
| Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes Y Chen, F Gao, F Chu, H Peng, L Zong, Y Liu, P Tien, GF Gao Journal of molecular biology 386 (3), 841-853, 2009 | 29 | 2009 |
| Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome FS Wang, FL Chu, L Jin, YG Li, Z Zhang, D Xu, M Shi, H Wu, JM Moulds Clinical & Experimental Immunology 139 (1), 112-119, 2005 | 26 | 2005 |
| Genetic variation of SARS coronavirus in Beijing hospital D Xu, Z Zhang, F Chu, Y Li, L Jin, L Zhang, GF Gao, FS Wang Emerging infectious diseases 10 (5), 789, 2004 | 26 | 2004 |
| Versatile CAR T-cells for cancer immunotherapy F Chu, J Cao, SS Neelalpu Contemporary Oncology/Współczesna Onkologia 2018 (1), 73-80, 2018 | 25 | 2018 |
| Crystal structure of a bony fish β2-microglobulin: insights into the evolutionary origin of immunoglobulin superfamily constant molecules W Chen, F Gao, F Chu, J Zhang, GF Gao, C Xia Journal of biological chemistry 285 (29), 22505-22512, 2010 | 25 | 2010 |
